跳至主要内容
临床试验/CTRI/2025/10/095611
CTRI/2025/10/095611尚未招募不适用

Randomized study on the impact of Homoeopathic Materia Medica by J T Kent based prescribing for the treatment of Migraine

Tantia University1 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2025年11月27日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
96
试验地点
1
主要终点
Changes will be observed on Migraine Disability Assessment Scale (MIDAS) measuring pain intensity

研究概览

简要总结

This study is to assess the impact of medicine selected from Repertory of homoeopathic materia medica by J T Kent for the treatment of migraine

sample size 96

12 months study

scale used - Migraine Disablity Assesment Scale (MIDAS)

It is expected to give positive changes

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed with Migraine either with or without aura.
  • Willing to pareticipate with informed concent.

排除标准

  • Patient on long term allopathic treatment for any of the disease
  • Other types of headache (tension , cluster, secondary) 3.Patient with psychiatric or neurological disorder
  • Patient undergoing any surgery
  • Patient with severe neuro-systemic disease, pregnant ladies.

结局指标

主要结局

Changes will be observed on Migraine Disability Assessment Scale (MIDAS) measuring pain intensity

时间窗: 12 months study

changes can be positive , negative or no change

时间窗: 12 months study

次要结局

  • Health related quantity of life(12 months)

研究者

发起方
Tantia University
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Harshit Kumar

Sri Ganganagar Homeopathic Medical College Hospital And Research Institute

研究点 (1)

Loading locations...

相似试验